RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sam Chun Dang Pharm Co Stock

Sam Chun Dang Pharm Co ROA 2025

Sam Chun Dang Pharm Co ROA

-0.02

Ticker

000250.KQ

ISIN

KR7000250001

In 2025, Sam Chun Dang Pharm Co's return on assets (ROA) was -0.02, a -17.47% increase from the -0.03 ROA in the previous year.

Sam Chun Dang Pharm Co Aktienanalyse

What does Sam Chun Dang Pharm Co do?

Sam Chun Dang Pharm Co Ltd is a pharmaceutical company specializing in Korean herbal medicine. It was founded in 1947 and is headquartered in Seoul, South Korea. The company has undergone a profound transformation in recent decades to meet the growing demands of the healthcare industry. Sam Chun Dang believes that natural remedies can play an important role in promoting health and well-being. Therefore, the company has focused on manufacturing medicines from natural herbs and plants. Since its inception, the company has aimed for better healthcare and improved quality of life for its customers. In recent years, Sam Chun Dang has become the market leader in the production of herbal medicine in Korea. It produces a variety of medicines, including products for treating traditional Korean ailments such as fatigue, loss of appetite, and colds. The company maintains several research centers and production facilities to ensure the preservation of its products' high quality. These centers are equipped with state-of-the-art equipment and have carefully trained personnel. Sam Chun Dang essentially produces three types of products: herbal medicine, dietary supplements, and health products. Herbal medicine is made from natural ingredients such as ginseng, horsetail, angelica, atractylodes, and many other herbs. Each product undergoes strict control and testing to ensure they meet the highest standards. Sam Chun Dang also produces dietary supplements that possess a wide range of health-promoting properties. These supplements contain vitamins, minerals, proteins, and many other nutrients. They are designed to naturally promote and strengthen the body's health. Additionally, Sam Chun Dang also offers health products such as masks and cleansing products. These products aim to help improve the health and well-being of customers. Sam Chun Dang is an innovative company that is always striving to improve its products and services. Over the years, the company has received several awards recognizing its leadership qualities and innovative products. Overall, Sam Chun Dang Pharm Co Ltd is a leading manufacturer of herbal medicine and dietary supplements with a strong commitment to health. The company has made a name for itself in recent years through its dedication and innovations in manufacturing products from natural ingredients. Sam Chun Dang remains committed to making a positive contribution to the healthcare industry while continuing to provide high-quality and innovative products. Sam Chun Dang Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Sam Chun Dang Pharm Co's Return on Assets (ROA)

Sam Chun Dang Pharm Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Sam Chun Dang Pharm Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Sam Chun Dang Pharm Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Sam Chun Dang Pharm Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Sam Chun Dang Pharm Co stock

What is the Return on Assets (ROA) of Sam Chun Dang Pharm Co this year?

The Return on Assets (ROA) of Sam Chun Dang Pharm Co is -0.02 undefined this year.

What was the ROA of Sam Chun Dang Pharm Co compared to the previous year?

The ROA of Sam Chun Dang Pharm Co has increased by -17.47% compared to the previous year.

What consequences do high ROA have for investors of Sam Chun Dang Pharm Co?

A high ROA is advantageous for investors of Sam Chun Dang Pharm Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Sam Chun Dang Pharm Co?

A low ROA can be unfavorable for investors of Sam Chun Dang Pharm Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Sam Chun Dang Pharm Co affect the company?

An increase in ROA of Sam Chun Dang Pharm Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Sam Chun Dang Pharm Co impact the company?

A reduction in the ROA of Sam Chun Dang Pharm Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Sam Chun Dang Pharm Co?

Some factors that can influence the ROA of Sam Chun Dang Pharm Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Sam Chun Dang Pharm Co important for investors?

The ROA of Sam Chun Dang Pharm Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Sam Chun Dang Pharm Co take to improve ROA?

To improve ROA, Sam Chun Dang Pharm Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Sam Chun Dang Pharm Co pay?

Over the past 12 months, Sam Chun Dang Pharm Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.1 %. For the coming 12 months, Sam Chun Dang Pharm Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Sam Chun Dang Pharm Co?

The current dividend yield of Sam Chun Dang Pharm Co is 0.1 %.

When does Sam Chun Dang Pharm Co pay dividends?

Sam Chun Dang Pharm Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Sam Chun Dang Pharm Co?

Sam Chun Dang Pharm Co paid dividends every year for the past 1 years.

What is the dividend of Sam Chun Dang Pharm Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.1 %.

In which sector is Sam Chun Dang Pharm Co located?

Sam Chun Dang Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sam Chun Dang Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sam Chun Dang Pharm Co from 4/1/2025 amounting to 200 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Sam Chun Dang Pharm Co pay the last dividend?

The last dividend was paid out on 4/1/2025.

What was the dividend of Sam Chun Dang Pharm Co in the year 2024?

In the year 2024, Sam Chun Dang Pharm Co distributed 0 KRW as dividends.

In which currency does Sam Chun Dang Pharm Co pay out the dividend?

The dividends of Sam Chun Dang Pharm Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sam Chun Dang Pharm Co

Our stock analysis for Sam Chun Dang Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sam Chun Dang Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.